187 related articles for article (PubMed ID: 9729536)
1. Role of arachidonic acid and its metabolites in the priming of NADPH oxidase in human polymorphonuclear leukocytes by peritoneal dialysis effluent.
Daniels I; Lindsay MA; Keany CI; Burden RP; Fletcher J; Haynes AP
Clin Diagn Lab Immunol; 1998 Sep; 5(5):683-9. PubMed ID: 9729536
[TBL] [Abstract][Full Text] [Related]
2. Phospholipases and the activation and priming of neutrophils by peritoneal dialysis effluent.
Lindsay MA; Daniels I; Fletcher J
Perit Dial Int; 1997; 17(5):471-9. PubMed ID: 9358529
[TBL] [Abstract][Full Text] [Related]
3. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
[TBL] [Abstract][Full Text] [Related]
4. The regulation of neutrophil phospholipase A2 by granulocyte-macrophage colony-stimulating factor and its role in priming superoxide production.
Roberts PJ; Williams SL; Linch DC
Br J Haematol; 1996 Mar; 92(4):804-14. PubMed ID: 8616070
[TBL] [Abstract][Full Text] [Related]
5. Activation and priming of neutrophil nicotinamide adenine dinucleotide phosphate oxidase and phospholipase A(2) are dissociated by inhibitors of the kinases p42(ERK2) and p38(SAPK) and by methyl arachidonyl fluorophosphonate, the dual inhibitor of cytosolic and calcium-independent phospholipase A(2).
Mollapour E; Linch DC; Roberts PJ
Blood; 2001 Apr; 97(8):2469-77. PubMed ID: 11290612
[TBL] [Abstract][Full Text] [Related]
6. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils.
Surette ME; Dallaire N; Jean N; Picard S; Borgeat P
FASEB J; 1998 Nov; 12(14):1521-31. PubMed ID: 9806761
[TBL] [Abstract][Full Text] [Related]
8. Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function.
Barnette MS; Rush J; Marshall LA; Foley JJ; Schmidt DB; Sarau HM
Biochem Pharmacol; 1994 Apr; 47(9):1661-7. PubMed ID: 8185681
[TBL] [Abstract][Full Text] [Related]
9. The requirement for phospholipase A2 for activation of the assembled NADPH oxidase in human neutrophils.
Dana R; Malech HL; Levy R
Biochem J; 1994 Jan; 297 ( Pt 1)(Pt 1):217-23. PubMed ID: 8280102
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CD11b/CD18 expression in human neutrophils by phospholipase A2.
Jacobson PB; Schrier DJ
J Immunol; 1993 Nov; 151(10):5639-52. PubMed ID: 8228253
[TBL] [Abstract][Full Text] [Related]
11. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation.
Payá M; Terencio MC; Ferrándiz ML; Alcaraz MJ
Br J Pharmacol; 1996 Apr; 117(8):1773-9. PubMed ID: 8732290
[TBL] [Abstract][Full Text] [Related]
12. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.
Glaser KB; Sung ML; Hartman DA; Lock YW; Bauer J; Walter T; Carlson RP
Skin Pharmacol; 1995; 8(6):300-8. PubMed ID: 8688196
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic Acid.
Wong RK; Pettit AI; Quinn PA; Jennings SC; Davies JE; Ng LL
Circulation; 2003 Oct; 108(15):1858-64. PubMed ID: 12963645
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of phospholipase A2 activities and some inflammatory responses by the marine product ircinin.
Cholbi R; Ferrándiz ML; Terencio MC; De Rosa S; Alcaraz MJ; Payá M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):677-83. PubMed ID: 8938669
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase A2 is involved in the mechanism of activation of neutrophils by polychlorinated biphenyls.
Tithof PK; Schiamberg E; Peters-Golden M; Ganey PE
Environ Health Perspect; 1996 Jan; 104(1):52-8. PubMed ID: 8834862
[TBL] [Abstract][Full Text] [Related]
17. Superoxide generation is inhibited by phospholipase A2 inhibitors. Role for phospholipase A2 in the activation of the NADPH oxidase.
Henderson LM; Chappell JB; Jones OT
Biochem J; 1989 Nov; 264(1):249-55. PubMed ID: 2557829
[TBL] [Abstract][Full Text] [Related]
18. Regulation of leukotriene and platelet-activating factor synthesis in human alveolar macrophages.
Shamsuddin M; Chen E; Anderson J; Smith LJ
J Lab Clin Med; 1997 Dec; 130(6):615-26. PubMed ID: 9422335
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene B4 stimulates the release of arachidonate in human neutrophils via the action of cytosolic phospholipase A2.
Burke JR; Davern LB; Gregor KR; Tramposch KM
Biochim Biophys Acta; 1997 Oct; 1359(1):80-8. PubMed ID: 9398088
[TBL] [Abstract][Full Text] [Related]
20. 5-Lipoxygenase products modulate the activity of the 85-kDa phospholipase A2 in human neutrophils.
Wijkander J; O'Flaherty JT; Nixon AB; Wykle RL
J Biol Chem; 1995 Nov; 270(44):26543-9. PubMed ID: 7592874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
